(Q45194944)

10 December 2017

title

Outcomes and early revascularization for patients > or = 65 years of age with cardiogenic shock (English)

1 reference

10 December 2017

1 reference

1 reference

Dauerman HL

1

1 reference

10 December 2017

Goldberg RJ

2

1 reference

10 December 2017

Malinski M

3

1 reference

10 December 2017

Yarzebski J

4

1 reference

10 December 2017

Lessard D

5

1 reference

10 December 2017

Gore JM

6

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

10 December 2017

published in

1 reference

10 December 2017

volume

87

1 reference

10 December 2017

issue

7

1 reference

10 December 2017

page(s)

844-848

1 reference

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Temporal trends in cardiogenic shock complicating acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. The REGICOR Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Impact of an Aggressive Invasive Catheterization and Revascularization Strategy on Mortality in Patients With Cardiogenic Shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myoca

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial In

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Recent insights into coronary collateral circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901524-1

10.1016/S0002-9149(00)01524-1

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference